188
Arexvy and Abrysvo RSV vaccines prove cost-effective for U.S. seniors, slashing RSV illness risks. At $127 and $118 per dose, they offer substantial health savings, with potential budget impacts up to $6.78 billion in the first season, emphasizing their value in elder care.
Author
Account Strength
100%
Account Age
9 years
Verified Email
Yes
Verified Flair
No
Total Karma
780,777
Link Karma
548,278
Comment Karma
213,213
Profile updated: 4 months ago
Posts updated: 9 months ago
Subreddit
Post Details
We try to extract some basic information from the post title. This is not
always successful or accurate, please use your best judgement and compare
these values to the post title and body for confirmation.
- Posted
- 11 months ago
- Reddit URL
- View post on reddit.com
- External URL
- medicine.yale.edu/news-a...